The North Central London Joint Formulary Committee – NCL JFC – advises Commissioners and Provider Trusts in NCL on appropriate, equitable, evidence-based and cost-effective medicines use. The JFC scientifically assesses medicines in terms of comparative efficacy, safety, convenience and cost-effectiveness. The current remit of JFC is thus scientific and advisory in nature and hence makes recommendations to accountable budget holders. The JFC is driven by an evidence-based approach and new medicines will be recommended if they offer a significant advantage over existing products. If the NHS is to afford to pay for new medicines which are expensive but offer a real clinical advantage we need to rigorously exclude those which incur cost but are essentially ‘me-too’ drugs and/or offer no clear advantage.
The triage process by which new drug applications are distributed between local Trust Drugs and Therapeutics Committee (DTCs) and NCL JFC is provided below.
Our Terms of Reference (ToR), meeting dates & membership, minutes and forms & templates are also provided.